BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6452523)

  • 1. Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis.
    Abdou NI; Lindsley HB; Racela LS; Pascual E; Hassanein KM
    J Rheumatol; 1981; 8(1):9-18. PubMed ID: 6452523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cell activity in patients with rheumatoid arthritis.
    Smolen JS; Lanzer G; Scherak O; Menzel EJ; Steffen C; Knapp W
    Agents Actions Suppl; 1980; 7():204-7. PubMed ID: 6454336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonspecific suppressor cells in rheumatoid arthritis. Con A and PHA induced suppressor cell activity.
    Dunne JV; Sengar DP; Pearson D; McKendry RJ; Gardell D
    J Clin Lab Immunol; 1982 Nov; 9(2):99-104. PubMed ID: 6218307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
    Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
    Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of suppressor T cells in rheumatoid arthritis patients: analysis of peripheral blood lymphocytes by 2-dimensional flow cytometry.
    Goto M; Miyamoto T; Nishioka K; Okumura K
    J Rheumatol; 1986 Oct; 13(5):853-7. PubMed ID: 2950232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of defective T lymphocyte-suppressor activating factor interaction in patients with rheumatoid arthritis.
    Keystone EC; Budz-Tymkewycz S; Toews M; Lau C
    Clin Exp Immunol; 1987 Jul; 69(1):48-56. PubMed ID: 2958193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
    Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
    Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells.
    Sakane T; Takada S; Murakawa Y; Kotani H; Honda M; Ueda Y
    J Immunol; 1982 Nov; 129(5):1972-7. PubMed ID: 6214584
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
    Kao JK; Hsue YT; Lin CY
    J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective IL2 production in active rheumatoid arthritis. Regulation by radiosensitive suppressor cells.
    Cathely G; Amor B; Fournier C
    Clin Rheumatol; 1986 Dec; 5(4):482-92. PubMed ID: 2949912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin.
    Zatz MM; Oliver J; Goldstein AL; Novak C; Jacobs RP
    Thymus; 1984; 6(4):205-18. PubMed ID: 6238454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
    Tian X; Zhao Y; Li ZG
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for activated peripheral blood T-cells in rheumatoid arthritis.
    Keystone EC; Shore A; Miller RG; Tan P; Poplonski L; Leary P; Albert S
    J Rheumatol Suppl; 1983 Dec; 11():85-92. PubMed ID: 6230449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
    Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonspecific suppressor function in rheumatoid arthritis.
    Panush RS
    J Clin Lab Immunol; 1982 Oct; 9(1):59-64. PubMed ID: 6217341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation in rheumatoid arthritis: evaluation of T lymphocyte function in the control of polyclonal immunoglobulin synthesis in vitro.
    Bellamy N; Cairns E; Bell DA
    J Rheumatol; 1983 Feb; 10(1):19-27. PubMed ID: 6221098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilized IgG-aggregate-induced cytolytic activity of lymphocytes from patients with rheumatoid arthritis.
    Fuson EW; Whittaker RL; Beard MR
    J Clin Lab Immunol; 1984 Dec; 15(4):181-6. PubMed ID: 6241257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.